Evolus (EOLS) Stocklytics Forecast

Evolus Inc (EOLS) is a pharmaceutical company focused on developing and commercializing innovative products for aesthetic medicine. The company's flagship product is Jeuveau, a neurotoxin that is used to treat frown lines between the eyebrows. Jeuveau has been approved by the U.S. Food and Drug Administration (FDA) and is gaining popularity among both patients and healthcare professionals.

As for the stock price prediction of Evolus Inc, a comprehensive analysis of various factors is required to make an accurate forecast. However, it's important to note that stock price predictions are speculative in nature and should not be solely relied upon for investment decisions. That being said, several analysts have provided their price targets for EOLS stock. These targets are based on their assessments of the company's financial performance, market conditions, and other relevant factors.